The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...
US alliance to accelerate next‑generation oral monoclonal antibody therapies Liège, Belgium, and Roanoke (VA), USA, March 18, ...
Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by decades of advances in discovery, engineering, and manufacturing. | As ...
Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...
The respiratory illness RSV is still going strong in Chicago – an unusually late showing for the virus, which can strike ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
The biomarker data presented at AD/PD 2026 from the Phase III APOLLOE4 trial showed that in the MCI subgroup, ...
Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.
A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...
CERRITOS, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Liminatus today announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results